Clinical and angiographic results of percutaneous coronary revascularization using a trilayer stainless steel-tantalum-stainless steel phosphorylcholine-coated stent: The Trimaxx trial

Catheterization and Cardiovascular Interventions

Volumn 70, Issue 7, 2007, Pages 914-919

  Abizaid, Alexandre ^a   Popma, Jeffrey J ^b   Tanajura, Luis F ^a   Hattori, Kyoko ^c   Solberg, Brad ^c   Larracas, Cristina ^c   Feres, Fausto ^a   De Ribamar Costa Jr , José ^a   Schwartz, Lewis B ^c  

^a INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c ABBOTT LABORATORIES   (United States)

Author keywords

Coronary stents; Percutaneous coronary intervention; Restenosis

Indexed keywords

PHOSPHORYLCHOLINE; STAINLESS STEEL; TANTALUM;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTICLE; BRAZIL; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; FEMALE; FOLLOW UP; GERMANY; HEART DEATH; HEART INFARCTION; HUMAN; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; Q WAVE; REVASCULARIZATION; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BRAZIL; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY STENOSIS; DRUG-ELUTING STENTS; FEASIBILITY STUDIES; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; PHOSPHORYLCHOLINE; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; SEVERITY OF ILLNESS INDEX; STAINLESS STEEL; TANTALUM; TIME FACTORS; TREATMENT OUTCOME;

EID: 38049024021     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21279     Document Type: Article

References (16)

1. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE. Sirolimus-eluting stents versus standard stents in patients with Stenosis in a native coronary artery. New Engl J Med 2003;349:1315-1323.
2. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME. A polymer-based paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-231.
3. Fajadet J, Wijns W, Laarman G-J, Kuck K-H, Ormiston J, Münzel T, Popma JJ, Fitzgerald PJ, Bonan R, Kuntz RE. Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine- encapsulated stent for treatment of native coronary artery lesions: Clinical and angiographic results of the ENDEAVOR II trial. Circulation 2006;114:798-806.
4. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G, Airoldi F, Chieffo A, Montorfano M, Carlino M, Michev I, Corvaja N, Briguori C, Gerckens U, Grube E, Colombo A. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005;293:2126-2130.
5. Kaiser C, Brunner-La Rocca HP, Buser PT, Bonetti PO, Osswald S, Linka A, Bernheim A, Zutter A, Zellweger M, Grize L. Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: Randomised Basel Stent Kosten Effektivitäts Trial (BASKET). Lancet 2005;366:921.
6. American College of Cardiology Foundation and the American Heart Association.ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention), 2006.
7. Silber S, Albertsson P, Aviles FF, Camici PG, Colombo A, Hamm C, Jorgensen E, Marco J, Nordrehaug J-E, Ruzyllo W, Urban P, Stone GW, Wijns W. Guidelines for percutaneous coronary interventions of the European Society of Cardiology. Eur Heart J 2005;26:804-847.
8. Lewis AL, Cumming ZL, Goreish HH, Kirkwood LC, Tolhurst LA, Stratford PW. Crosslinkable coatings from phosphorylcholine-based polymers. Biomaterials 2001;22:99-111.
9. Sketch MH Jr., Ball M, Rutherford B, Popma JJ, Russell C, Kereiakes DJ. Evaluation of the medtronic (Driver) cobalt-chromium alloy coronary stent system. Am J Cardiol 2005;95: 8-12.
10. Kereiakes DJ, Cox DA, Hermiller JB, Midei MG, Bachinsky WB, Nukta ED, Leon MB, Fink S, Marin L, Lansky A. Usefulness of a cobalt chromium coronary stent alloy. Am J Cardiol 2003;92:463-466.
11. Pache J, Kastrati A, Mehilli J, Schuhlen H, Dotzer F, Hausleiter J, Fleckenstein M, Neumann F-J, Sattelberger U, Schmitt C, Muller M, Dirschinger J, Schomig A. Intracoronary stenting and angiographic results: Strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial. J Am Coll Card 2003;41:1283-1288.
12. Lau K-W, Mak K-H, Hung J-S, Sigwart U. Clinical impact of stent construction and design in percutaneous coronary intervention. Am Heart J 2004;147:764-773.
13. Baim DS, Flatley M, Caputo R, O'Shaughnessy C, Low R, Fanelli C, Popma I, Fitzgerald P, Kuntz RE. Comparison of prediction vs. direct stenting in coronary treatment using the Medtronic AVE S670 coronary stent system (The PREDICT Study). Am J Cardiol 2001;88:1364-1369.
14. Kereiakes DJ, Midei M, Hermiller J, O'Shaughnessy C, Schlofmitz R, Yakubov S, Fink S, Hu F, Nishimura N, Sievers M, Valentine ME, Broderick T, Lansky A, Moses J. Procedural and late outcomes following MULTI-LINK DUET coronary stent deployment. Am J Cardiol 1999;84:1385-1390.
15. Zidar JP, Fry E, Lambert C, Rubenstein R, Raizner AE, Fischell A, Janzer S, Popma JJ, Kuntz RE. VENUS study: A multicenter registry of the Cordis Bx Velocity™ stent (abstract). Am J Cardiol 2000;86(Supplement I):118i.
16. Mauri L, Orav EJ, Candia SC, Cutlip DE, Kuntz RE. Robustness of late lumen loss in discriminating drug-eluting stents across variable observational and randomized trials. Circulation 2005;112:2833-2839.